Legal Experts Tout Need For More FDA Authority To Respond To Drug Shortages

Legal experts say Congress should give FDA new power to respond to shortages of critical drugs, floating the ideas of letting FDA temporarily re-purpose a drug license to another company, akin to NIH's march-in rights, and allowing importation from unregistered foreign manufacturers. The suggestions came a week after pharmaceutical engineers released a manufacturer-spearheaded drug shortage prevention plan that drew some praise from FDA and European regulatory officials. Charleston School of Law Professor William Janssen discussed the re-purposing idea at a...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.